ConductScience.org, home

Paper39456239

Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions.

Maqueda JJ and 2 others. Biomolecules, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions. Papers, record 39456239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39456239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions.
PubMed
Journal
Biomolecules
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.74, provisional
iCite
Revised in PubMed
2026-09-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maqueda JJJoaquín Jhttps://orcid.org/0000-0002-0800-4167
2De Feo AAlessandrahttps://orcid.org/0000-0002-9805-1361
3Scotlandi KKatiahttps://orcid.org/0000-0001-6114-9499

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
SarcomaMajor topic
Humans
Child
Liquid Biopsy
Prognosis
Rhabdomyosarcoma
Sarcoma, Ewing
Osteosarcoma
Bone Neoplasms

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 956285 (VAGABOND)MSCA - EU Horizon 2020 research and innovation programmePubMed
Ricerca CorrenteItalian Ministry of HealthPubMed

Source PubMed

Download CSV of grants

References145

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136652664Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.JCO Precis Oncol2023https://conductscience.org/library/papers/36652664PubMed
223665678TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma.Oncogene2014https://conductscience.org/library/papers/23665678PubMed
320103643EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.Cancer Res2010https://conductscience.org/library/papers/20103643PubMed
436044434Stability of circulating microRNAs in serum.PLoS One2022https://conductscience.org/library/papers/36044434PubMed
520637263Serum microRNAs as powerful cancer biomarkers.Biochim Biophys Acta2010https://conductscience.org/library/papers/20637263PubMed
68722221Detection of tyrosinase mRNA from the blood of melanoma patients.Cancer Epidemiol Biomarkers Prev1996https://conductscience.org/library/papers/8722221PubMed
730123735Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy.J Bone Oncol2018https://conductscience.org/library/papers/30123735PubMed
824448245Universal marker and detection tool for human sarcoma circulating tumor cells.Cancer Res2014https://conductscience.org/library/papers/24448245PubMed
936211364Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma.Front Immunol2022https://conductscience.org/library/papers/36211364PubMed
1026050619The biology of circulating tumor cells.Oncogene2016https://conductscience.org/library/papers/26050619PubMed
1129386915Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients.Cancer Manag Res2018https://conductscience.org/library/papers/29386915PubMed
1236551600The Role of Cell-Free DNA in Cancer Treatment Decision Making.Cancers (Basel)2022https://conductscience.org/library/papers/36551600PubMed
1331578374The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486.Sci Rep2019https://conductscience.org/library/papers/31578374PubMed
1435303879Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments.Mol Cancer2022https://conductscience.org/library/papers/35303879PubMed
1535117548Strategies for enrichment of circulating tumor cells.Transl Cancer Res2020https://conductscience.org/library/papers/35117548PubMed
1626349418Pediatric Rhabdomyosarcoma.Crit Rev Oncog2015https://conductscience.org/library/papers/26349418PubMed
1734050156Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.Nat Commun2021https://conductscience.org/library/papers/34050156PubMed
1829759550Sarcoma-The standard-bearer in cancer discovery.Crit Rev Oncol Hematol2018https://conductscience.org/library/papers/29759550PubMed
1932010687IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives.Front Cell Dev Biol2019https://conductscience.org/library/papers/32010687PubMed
2032359482Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living.Trends Mol Med2020https://conductscience.org/library/papers/32359482PubMed

See all 145 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42220429Circulating Tumor DNA and microRNA-Based Liquid Biopsy for Longitudinal Treatment Monitoring and Recurrence Prediction in Pediatric Sarcomas: A Prospective Cohort Study.Oncol Res2026https://conductscience.org/library/papers/42220429PubMed
42022572Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights.Front Pharmacol2026https://conductscience.org/library/papers/42022572PubMed
41987302A conceptual blueprint for "turning cold to hot" in Osteosarcoma: from TME stratification hypotheses to adaptive therapeutic prospects.Cell Commun Signal2026https://conductscience.org/library/papers/41987302PubMed
41816119From imaging to omics: deep learning is bridging MRI and liquid biopsy in bone tumor diagnosis.J Bone Oncol2026https://conductscience.org/library/papers/41816119PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39456239

GET https://conductscience.org/api/papers/v1/39456239/references?page=2